Cardiac monitoring devices market to hit $37.88 by 2031

Asia-Pacific is expected to post the highest growth rate.

The global cardiac monitoring and cardiac rhythm management devices market is expected to grow from $27.90b in 2026 to $37.88b by 2031, according to MarketsandMarkets.

Growth is driven by rising cardiovascular disease and arrhythmia cases, an aging population, and increasing rates of obesity and diabetes.

Adoption of minimally invasive and remote monitoring devices, expansion of home healthcare and telemedicine, favorable reimbursement in developed markets, and improving access to care in emerging economies are supporting demand.

Resting ECG devices are expected to dominate the market due to their routine use in cardiac screening, diagnosis, and monitoring. The test is non-invasive, low-cost, quick to perform, and widely available across hospitals, clinics, and ambulatory settings.

By application, arrhythmia is projected to register the highest CAGR. High prevalence of atrial fibrillation and ventricular arrhythmias, along with strong demand for pacemakers, ICDs, CRT systems, and advanced monitoring devices, continues to drive the segment.

Within pacemakers, leadless devices are expected to grow the fastest. These small, self-contained devices are implanted directly into the heart without leads, lowering the risk of infection and lead-related complications. Minimally invasive procedures and growing physician and patient preference are accelerating adoption.

Home care settings are projected to record the highest CAGR among end users, driven by increased use of wearable and portable defibrillators, remote monitoring, and telehealth. Healthcare systems are shifting toward home-based cardiac care to reduce hospital stays and readmissions.

Asia-Pacific is expected to post the highest growth rate, supported by rising cardiovascular disease rates, expanding healthcare infrastructure, growing awareness, and government initiatives promoting remote and home-based cardiac care.